These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2430039)

  • 1. Protease inhibitors of human plasma. Alpha-2-antiplasmin.
    Lijnen HR; Collen D
    J Med; 1985; 16(1-3):225-84. PubMed ID: 2430039
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique pathway for the plasma elimination of alpha 2-antiplasmin-protease complexes in mice.
    Gonias SL; Fuchs HE; Pizzo SV
    Thromb Haemost; 1982 Oct; 48(2):208-10. PubMed ID: 6758181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intensification of the effect of exogenous plasminogen activators on lysis of fibrin blood clots due to a decrease in the level of alpha-2- antiplasmin by a plasmasorption method].
    Ogloblina OG; Saburova OS; Semenova OA; Belova LA
    Biokhimiia; 1994 Jan; 59(1):62-8. PubMed ID: 7509643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of the inhibition of plasmin in acidified human plasma.
    Lijnen HR; Maes M; Castel M; Samama M; Collen D
    Thromb Haemost; 1982 Dec; 48(3):257-9. PubMed ID: 6219470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplasmin activity in carrageenin-induced inflammation of rats.
    Kosugi T; Kinjo K; Takagi I; Matsuo O; Mihara H; Nishikaze O
    Int J Tissue React; 1981 Dec; 3(3-4):173-6. PubMed ID: 7333644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methods of studying alpha 2-antiplasmin activity].
    Boiadzhiian KhP
    Vopr Med Khim; 1991; 37(5):92-4. PubMed ID: 1722061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplasmin: the forgotten serpin?
    Coughlin PB
    FEBS J; 2005 Oct; 272(19):4852-7. PubMed ID: 16176259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma antiplasmin activities in experimental lung insufficiency.
    Aasen AO; Saugstad OD; Lium B; Guldvog I; Lyngaas K; Larsbraaten M; Amundsen E
    Acta Chir Scand Suppl; 1980; 499():113-21. PubMed ID: 6935891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceleration of plasma clot lysis by an antibody to alpha 2-antiplasmin.
    Reed GL; Matsueda GR; Haber E
    Trans Assoc Am Physicians; 1988; 101():250-6. PubMed ID: 2480017
    [No Abstract]   [Full Text] [Related]  

  • 13. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.
    Kramer MD; Reinartz J
    J Clin Invest; 1993 Aug; 92(2):978-83. PubMed ID: 7688770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
    Holvoet P; de Boer A; Verstreken M; Collen D
    Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levels of plasminogen and alpha 2-antiplasmin in blood of patients with prostatic tumor].
    Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):86-8. PubMed ID: 8756739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of human extrinsic (tissue-type) plasminogen activator in human plasma: no evidence for a specific inhibitor.
    Korninger C; Collen D
    Thromb Haemost; 1981 Oct; 46(3):662-5. PubMed ID: 6171907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural protease inhibitors to fibrinolysis in liver diseases.
    Arnman R; Gyzander E; Hedner U; Olsson R; Teger-Nilsson AC
    Hepatogastroenterology; 1980 Aug; 27(4):254-8. PubMed ID: 6162766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of plasminogen binding site of alpha 2-plasmin inhibitor on the initiation and regulation of fibrinolysis].
    Iwamoto M; Sugiyama N
    Rinsho Byori; 1989 Apr; Spec No 81():118-25. PubMed ID: 2526883
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.
    Rijken DC; Groeneveld E; Kluft C; Nieuwenhuis HK
    Biochem J; 1988 Oct; 255(2):609-15. PubMed ID: 2974279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of the effects of thrombin activatable fibrinolysis inhibitor and alpha2-antiplasmin on fibrinolysis in normal human plasma.
    Nielsen VG; Ellis TC
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):29-33. PubMed ID: 17179823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.